Literature DB >> 28163489

Osteomyelitis of zygoma secondary to depressed fracture of parietal bone: Case report of a rare entity.

Ram Rangila1.   

Abstract

Osteomyelitis is an inflammatory condition of bone involving the medullary cavity, the Haversian system, and the adjacent cortex. According to literature review osteomyelitis of zygomatic bone secondary to the depressed fracture of the parietal bone never reported. Here we report a case of osteomyelitis of zygomatic bone which develops 3 month after the depressed fracture of parietal bone.

Entities:  

Keywords:  Hematogenous osteomyelitis; rare; zygoma

Year:  2016        PMID: 28163489      PMCID: PMC5242085          DOI: 10.4103/0975-5950.196138

Source DB:  PubMed          Journal:  Natl J Maxillofac Surg        ISSN: 0975-5950


  7 in total

Review 1.  Current concepts in posttraumatic osteomyelitis: a diagnostic challenge with new imaging options.

Authors:  Thomas Gross; Achim H Kaim; Pietro Regazzoni; Andreas F Widmer
Journal:  J Trauma       Date:  2002-06

Review 2.  Osteomyelitis.

Authors:  D P Lew; F A Waldvogel
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

Review 3.  Osteomyelitis: the past decade.

Authors:  F A Waldvogel; P S Papageorgiou
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

Review 4.  Acute and chronic adult osteomyelitis and prosthesis-related infections.

Authors:  P Muñoz; E Bouza
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  1999-03       Impact factor: 4.098

Review 5.  Infection and musculoskeletal conditions: Osteomyelitis.

Authors:  Irene G Sia; Elie F Berbari
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-12       Impact factor: 4.098

Review 6.  Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment.

Authors:  D W Haas; M P McAndrew
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

Review 7.  Osteomyelitis.

Authors:  Daniel P Lew; Francis A Waldvogel
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.